Advisory Alpha’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-95
Closed -$6K 507
2020
Q3
$6K Buy
+95
New +$6.21K ﹤0.01% 499
2020
Q2
Sell
-45
Closed -$2.74K 472
2020
Q1
$2.74K Buy
+45
New +$2.74K ﹤0.01% 568
2019
Q4
Sell
-204
Closed -$11.3K 882
2019
Q3
$11.3K Buy
+204
New +$11.7K ﹤0.01% 442
2019
Q2
Sell
-60
Closed -$3.78K 498
2019
Q1
$3.78K Buy
+60
New +$3.94K ﹤0.01% 493

Other funds holding PJP

Advisory Alpha's PJP Position: Q4 2020 in Review

Advisory Alpha sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2020, closing a stake of 95 shares — an estimated $6K sold.

Advisory Alpha first reported a position in PJP in Q1 2019 and held it in 4 quarters. The position peaked at $11.3K in Q3 2019. 87 funds tracked by Wall St. Rank hold PJP as of Q4 2020.

  • Advisory Alpha reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2020 after selling out during the quarter.
  • Advisory Alpha sold 95 Invesco Pharmaceuticals ETF shares in Q4 2020, an estimated $6K.
  • Advisory Alpha first reported a position in Invesco Pharmaceuticals ETF in Q1 2019 and held it in 4 quarters.
  • Advisory Alpha's Invesco Pharmaceuticals ETF position peaked at $11.3K in Q3 2019.
  • 87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.